FDA Announces Draft Guidance for Industry on Formal Meetings Between FDA and Sponsors or Applicants of Prescription Drug User Fee Act Products

Summary

The Food and Drug Administration (FDA) has released a draft guidance for industry outlining recommendations for formal meetings between the FDA and sponsors or applicants of prescription drug products, following the withdrawal of previous guidance documents.